Severin Vogt is a physician trained in clinical pharmacology & toxicology and internal medicine and works as a senior physician at the department of clinical pharmacology & toxicology at the University Hospital Basel. He is part of the psychopharmacology research group of Prof. Matthias Liechti where he investigates the pharmacology and function of psychoactive substances with a focus on N,N-Dimethyltryptamine (DMT). In a recently published study, he tested different administration regimes of intravenous DMT including continuous infusions and bolus doses. Currently, he conducts several clinical trials that investigate the dose-response relationship of intravenous DMT in detail. Furthermore, he aims at evaluating DMT for the treatment of pain disorders in future trials.